Biomea Fusion, Inc. (BMEA)

Latest Insider Confidence Score

2025Q4

56.8
Bullish

Company insider confidence (by quarter)

2021Q2 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Stergiopoulos Sotirios Director 4,400,000 Sep 21, 2021
Chen Bihua Director 3,570,872 Aug 1, 2025
Cormorant Asset Management, LP 10% Owner 3,570,872 Aug 1, 2025
Cormorant Global Healthcare Master Fund, LP 10% Owner 3,570,872 Aug 1, 2025
Cormorant Private Healthcare Fund III LP 10% Owner 3,570,872 Aug 1, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 31, 2025 Feb 6, 2026 Erdtmann Rainer M Officer Neutral 52.5 - 0.00% ✗ -
Dec 11, 2025 Dec 15, 2025 Erdtmann Rainer M Officer Buy 78.8 +30,000 1.18% ✗ $43K
Dec 2, 2025 Dec 4, 2025 Hitchcock Michael J.M. CEO Buy 95.0 +100,000 666.67% ✗ $99.2K
Nov 28, 2025 Dec 2, 2025 Erdtmann Rainer M Officer Buy 82.5 +50,000 2.01% ✗ $54.6K
Aug 11, 2025 Aug 13, 2025 Hitchcock Michael J.M. CEO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2025 Aug 13, 2025 Erdtmann Rainer M Officer Neutral 27.5 -40,000 -1.58% ✗ -
Aug 1, 2025 Chen Bihua Other Neutral 52.5 - 0.00% ✗ -
Jul 22, 2025 Jul 24, 2025 Averill Julianne Director Neutral 52.5 - 0.00% ✗ -
Jul 24, 2025 Averill Julianne Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Faust Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 AGUIAR ERIC Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 13, 2025 Chen Bihua Director Neutral 52.5 - 0.00% ✗ -
Mar 26, 2025 Mar 28, 2025 Hitchcock Michael J.M. CEO Neutral 52.5 - 0.00% ✗ -
Nov 30, 2024 Dec 2, 2024 Valle Franco CFO Neutral 77.5 +495 1.16% ✗ -
Sep 30, 2024 Oct 1, 2024 Hitchcock Michael J.M. Director Buy 95.0 +10,000 200.00% ✗ $100.6K
Jun 12, 2024 Jun 13, 2024 Chen Bihua Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Faust Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 Hitchcock Michael J.M. Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Jun 13, 2024 AGUIAR ERIC Director Neutral 52.5 - 0.00% ✗ -
May 31, 2024 Jun 12, 2024 Valle Franco CFO Buy 95.0 +16,957 66.39% ✗ $55.4K
May 31, 2024 Jun 12, 2024 Frias Juan Pablo Chief Medical Officer Neutral 90.0 +349 100.00% ✗ -
Jan 17, 2024 Jan 18, 2024 Butler Thomas Andrew CEO Neutral 52.5 - 0.00% ✗ -
Jan 17, 2024 Jan 18, 2024 Erdtmann Rainer M COO Neutral 52.5 - 0.00% ✗ -
Jan 17, 2024 Jan 18, 2024 Valle Franco CFO Neutral 52.5 - 0.00% ✗ -
Jan 17, 2024 Jan 18, 2024 Frias Juan Pablo Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 29, 2023 Jan 3, 2024 Erdtmann Rainer M COO Neutral 45.0 -12,000 -0.47% ✗ -
Nov 30, 2023 Dec 1, 2023 Valle Franco CFO Neutral 85.0 +1,345 5.56% ✗ -
Aug 31, 2023 Sep 1, 2023 Frias Juan Pablo Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Sep 1, 2023 Frias Juan Pablo Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Hitchcock Michael J.M. Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Chen Bihua Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Faust Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 AGUIAR ERIC Director Neutral 52.5 - 0.00% ✗ -
May 31, 2023 Jun 2, 2023 Valle Franco CFO Neutral 90.0 +4,273 21.45% ✗ -
May 31, 2023 Jun 2, 2023 A2A Pharmaceuticals, Inc. 10% Owner Sell 17.5 -125,000 -3.45% ✗ $4.3M
May 12, 2023 May 17, 2023 A2A Pharmaceuticals, Inc. 10% Owner Sell 30.0 -25,000 -0.68% ✗ $846K
May 8, 2023 May 10, 2023 A2A Pharmaceuticals, Inc. 10% Owner Sell 16.3 -250,000 -6.41% ✗ $8.6M
Apr 20, 2023 Apr 26, 2023 A2A Pharmaceuticals, Inc. 10% Owner Sell 16.3 -200,000 -4.88% ✗ $5.8M
Mar 31, 2023 Apr 6, 2023 A2A Pharmaceuticals, Inc. 10% Owner Sell 16.3 -200,000 -4.65% ✗ $6.3M
Mar 31, 2023 Apr 6, 2023 A2A Pharmaceuticals, Inc. 10% Owner Buy 96.3 +200,000 5.13% ✗ $6.3M
Mar 30, 2023 Apr 3, 2023 Chen Bihua Director Buy 100.0 +400,000 12.61% ✗ $12M
Jul 1, 2022 Feb 10, 2023 Erdtmann Rainer M COO Neutral 27.5 -203,100 -7.39% ✗ -
Apr 15, 2021 Feb 10, 2023 Erdtmann Rainer M COO Buy 95.0 +8,400 100.00% ✗ $142.8K
Jan 6, 2023 Jan 10, 2023 Erdtmann Rainer M COO Neutral 52.5 - 0.00% ✗ -
Jan 6, 2023 Jan 10, 2023 Valle Franco CFO Neutral 52.5 - 0.00% ✗ -
Jan 6, 2023 Jan 10, 2023 Butler Thomas Andrew CEO Neutral 52.5 - 0.00% ✗ -
Nov 30, 2022 Dec 2, 2022 Valle Franco CFO Neutral 90.0 +2,518 14.47% ✗ -
Nov 14, 2022 Nov 16, 2022 Hitchcock Michael J.M. Director Buy 91.3 +5,000 100.00% ✗ $39.7K
Nov 11, 2022 Nov 14, 2022 Valle Franco CFO Buy 91.3 +4,100 30.81% ✗ $31.3K
Aug 16, 2022 Aug 19, 2022 A2A Pharmaceuticals, Inc. 10% Owner Sell 30.0 -30,684 -0.71% ✗ $425.6K
Jul 21, 2022 Jul 25, 2022 A2A Pharmaceuticals, Inc. 10% Owner Sell 30.0 -34,658 -0.79% ✗ $388.5K
Jun 24, 2022 Jun 28, 2022 A2A Pharmaceuticals, Inc. 10% Owner Sell 30.0 -34,658 -0.79% ✗ $407.6K
Jun 22, 2022 Jun 24, 2022 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2022 Jun 24, 2022 Hitchcock Michael J.M. Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2022 Jun 24, 2022 AGUIAR ERIC Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2022 Jun 24, 2022 Faust Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jun 24, 2022 Faust Elizabeth Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2022 Jun 24, 2022 Chen Bihua Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2022 Jun 3, 2022 Biomea Health, LLC 10% Owner Neutral 27.5 -4,365,342 -100.00% ✗ -
May 31, 2022 Jun 1, 2022 Valle Franco CFO Neutral 90.0 +3,307 33.07% ✗ -
Mar 3, 2022 Mar 7, 2022 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Jan 14, 2022 Jan 18, 2022 Valle Franco CFO Buy 95.0 +10,000 100.00% ✗ $86.8K
Dec 4, 2021 Dec 7, 2021 Butler Thomas Andrew CEO Neutral 52.5 - 0.00% ✗ -
Dec 4, 2021 Dec 7, 2021 Erdtmann Rainer M COO Neutral 52.5 - 0.00% ✗ -
Dec 4, 2021 Dec 7, 2021 Valle Franco CFO Neutral 52.5 - 0.00% ✗ -
Sep 17, 2021 Sep 21, 2021 A2A Pharmaceuticals, Inc. 10% Owner Buy 75.0 +34,658 0.79% ✗ $379.9K
Sep 17, 2021 Sep 21, 2021 Stergiopoulos Sotirios Director Buy 75.0 +34,658 0.79% ✗ $379.9K
Aug 23, 2021 Aug 25, 2021 Erdtmann Rainer M COO Buy 92.5 +24,000 8.56% ✗ $316.9K
Aug 23, 2021 Aug 25, 2021 Butler Thomas Andrew CEO Buy 90.0 +24,000 4.66% ✗ $316.9K
Apr 15, 2021 Aug 19, 2021 Erdtmann Rainer M COO Buy 100.0 +204,470 268.83% ✗ $3.3M
Apr 15, 2021 Aug 19, 2021 Butler Thomas Andrew CEO Buy 100.0 +204,470 65.80% ✗ $3.3M
Aug 3, 2021 Aug 5, 2021 Valle Franco CFO Neutral 52.5 - 0.00% ✗ -
Aug 5, 2021 Valle Franco CFO Neutral 52.5 - 0.00% ✗ -
Jun 16, 2021 Jun 21, 2021 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2021 Ray Sumita Director Neutral 52.5 - 0.00% ✗ -
Apr 26, 2021 A2A Pharmaceuticals, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 20, 2021 Apr 22, 2021 Chen Bihua Director Buy 100.0 +900,000 39.63% ✗ $15.3M
Apr 15, 2021 Apr 19, 2021 Cormorant Asset Management, LP Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Apr 19, 2021 AGUIAR ERIC Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Apr 19, 2021 Stergiopoulos Sotirios Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Apr 19, 2021 Hitchcock Michael J.M. Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Erdtmann Rainer M COO Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Butler Thomas Andrew CEO Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Hitchcock Michael J.M. Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Ryan Sunny EVP of Finance Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Biomea Health, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 AGUIAR ERIC Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Stergiopoulos Sotirios Director Neutral 52.5 - 0.00% ✗ -
Apr 15, 2021 Chen Bihua Director Neutral 52.5 - 0.00% ✗ -